Dominick P. Purpura Department of Neuroscience

About the Department - OLD Design


We are on the threshold of an unprecedented period of discovery in neuroscience. Recent advances in genetics and cellular and molecular biology have provided remarkable insights into the control of neural development, the potential repair of neural damage, and the elucidation of basic mechanisms underlying learning and memory, as well as disorders of the nervous system.

In parallel, the advent of tools that can be used to examine neural function at a systems level (e.g., fMRI and computational techniques) have allowed data from molecular and cellular studies to be integrated with aspects of complex behaviors. This progress stands us in good stead for translating basic science findings to clinically relevant outcomes.

Neuroscience tends to be an eclectic discipline, and students in the department examine the structural and functional organization of the nervous system from multiple scientific perspectives and using a variety of techniques. Though departmental life is centered around the laboratory, students and faculty stay connected through a series of weekly seminars, works-in-progress sessions, journal clubs, and mini-courses on select topics. We have a strong commitment to graduate education, and the department offers a series of three Neuroscience courses augmented by select advanced programs. We encourage prospective students to stop by and see what our program has to offer.

Founding Principle

The Department of Neuroscience has been guided since its inception by the principle that Neuroscience is not a discipline, but a way of thinking about and approaching problems of nervous system structure and function. This philosophy has sustained a climate of strong and effective multidisciplinary collaborations among electrophysiologists, cellular and molecular neurobiologists, neurochemists, cognitive neuroscientists, etc. The continuing success of our faculty and students in the competitive universe of neuroscience discourse testifies to the validity of this doctrine.

A Brief History

The Department of Neuroscience was founded in 1974 to create a formal academic program for enhancing collaborative research and training in studies of a wide variety of nervous systems. Dr. Dominick P. Purpura, founding Chairman, also served as Director of the Rose F. Kennedy Center, a relationship that facilitated the growth and development of the Department within the Center. Following Dr. Purpura's departure to Stanford as Dean, Dr. Michael V.L. Bennett assumed the Chairmanship and was succeeded by Dr. Joseph Arezzo as Interim Chair. In 1999, Dr. Donald Faber became Chairman of Neuroscience and Director of the Kennedy Center, thus ensuring a continuing growth of the Department within the Center, which over time has become a center for brain sciences. Presently, Dr. Kamran Khodakhah (who had served as Interim Chair since 2013) has assumed the role of Chairman, succeeding Dr. Faber. Under Dr. Khodakhah’s leadership, The Brain Science Initiative will further strengthen the commitment to brain research excellence at Einstein and Montefiore. 

Recent News & Events

Grant Award | Dr. Scott Emmons
The National Institute of Mental Health has awarded Scott W. Emmons, Ph.D., a five-year, $2 million grant to investigate the synaptic connections that allow signals to travel from neuron to neuron throughout the brain. The researchers will conduct their studies on the nematode worm Caenorhabditis elegans, which depends on genes similar to those that lay down the neuronal architecture in human brains. Through a combination of genetic, molecular and biochemical studies, the research should shed light on the function of these genes and the factors that make accurate nerve connectivity possible. Dr. Emmons is professor of genetics and of neuroscience and holds the Siegfried Ullmann Chair in Molecular Genetics. (1R01MH112689-01)...more

Publication | Dr. Steve Walkley
Steven Walkley, D.V.M., Ph.D., has co-authored a study in the August 10 issue of The Lancet showing that the drug 2-hydroxypropyl-β-cyclodextrin (HPβCD) can safely slow NPC1's progression. Patients received monthly or bi-weekly spinal injections of the drug for 18 months. Following the treatment period, biochemical and neurological tests showed that, compared with historical data for patients the same age, patients treated with the drug experienced significantly less cognitive dysfunction, with minimal side effects. Dr. Walkley is director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, in the department of pathology, and in the Saul R. Korey Department of Neurology at Einstein....more

more news and events


Contact Us

Rose F. Kennedy Center

1410 Pelham Parkway South

9th Floor

Bronx, NY 10461

Phone: 718-430-2408

Fax: 718-430-8821

Click here to log in